Citadel Advisors - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is and the CUSIP is 98973P951. A total of 2 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q2 2016$506,000
+78.2%
92,100
+140.5%
0.00%
Q1 2016$284,000
-80.9%
38,300
-78.6%
0.00%
-100.0%
Q4 2015$1,489,000
+257.9%
179,200
+287.9%
0.00%
Q3 2015$416,000
-54.8%
46,200
-39.8%
0.00%
-100.0%
Q2 2015$920,000
+15.4%
76,700
+3.6%
0.00%0.0%
Q1 2015$797,000
+254.2%
74,000
+66.7%
0.00%
Q4 2014$225,000
+100.9%
44,400
+4.5%
0.00%
Q3 2014$112,000
+1.8%
42,500
+55.1%
0.00%
Q2 2014$110,000
-13.4%
27,400
-1.1%
0.00%
Q1 2014$127,000
+0.8%
27,700
-4.5%
0.00%
Q4 2013$126,000
+137.7%
29,000
+116.4%
0.00%
Q3 2013$53,000
-64.2%
13,400
-80.9%
0.00%
Q2 2013$148,00070,3000.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2016
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 37,200$23,4360.00%
SIMPLEX TRADING, LLC 13,700$80.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ZIOPHARM ONCOLOGY INC shareholders